Free Trial
→ Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX (From InvestorPlace) (Ad)tc pixel
NASDAQ:IMA

ImageneBio 5/7/2026 Earnings Report

ImageneBio logo
$5.53 -0.38 (-6.50%)
As of 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

ImageneBio EPS Results

Actual EPS
-$0.95
Consensus EPS
-$0.70
Beat/Miss
Missed by -$0.25
One Year Ago EPS
N/A

ImageneBio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ImageneBio Announcement Details

Quarter
Date
5/7/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

ImageneBio Earnings Headlines

ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
May 7 at 4:05 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/07/3290583/0/en/imagenebio-reports-first-quarter-2026-financial-results-and-provides-img-007-program-update.html
ImageneBio Inc.
April 13, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/ima/company-people
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and spotted Amazon when it was still considered a bookstore - moves followed by gains of 249,900%, 112,700%, and 216,100%. Now Gilder has identified three companies building a new chip architecture he calls the 'Trillion Dollar Triangle' - one that could make current AI data centers obsolete. One company designed it, one can build it at scale, and a third is preparing to go public.tc pixel
May 8 at 1:00 AM  |  Eagle Publishing (Ad)
IMA stock surges 24%, breaks 50-DMA for first time since February – what's driving the rally?
April 13, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/ima-stock-surges-24-breaks-50-dma-for-first-time-since-february-whats-driving-the-rally/ar-AA20Ns5C
ImageneBio $30 Million Private Placement Ignites Stock
April 13, 2026  |  benzinga.comhttps://www.benzinga.com/news/health-care/26/04/51787885/imagenebio-30-million-private-placement-ignites-stock
ImageneBio, Inc. Secures $30 Million in Private Placement Led by Coastlands Capital to Advance IMG-007 Development
April 13, 2026  |  quiverquant.comQ
See More ImageneBio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ImageneBio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImageneBio and other key companies, straight to your email.

About ImageneBio

ImageneBio (NASDAQ:IMA), a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

View ImageneBio Profile
Earnings Tools